Lv0
0 积分 2023-11-10 加入
Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII
3天前
已完结
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
3天前
已完结
Non-small-cell lung cancer
8天前
已完结
Current landscape of CD3 bispecific antibodies in hematologic malignancies
26天前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
26天前
已完结
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
26天前
已完结
Lupus nephritis-related chronic kidney disease
3个月前
已完结
Vascular damage in systemic lupus erythematosus
3个月前
已完结
PK and PD Ligand-Binding Assays in Large Molecule Drug Development
3个月前
已完结
Integrin-based therapeutics: biological basis, clinical use and new drugs
3个月前
已完结
皖公网安备34019202002308
